Experienced in Thrombocytopenia

Brett L. Houston

Cancercare Manitoba
Winnipeg, MB, CA 
Experienced in Thrombocytopenia
Cancercare Manitoba
Winnipeg, MB, CA 
OverviewLocationsClinical Research

Overview

Brett Houston practices in Winnipeg, Canada. Mr. Houston is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Sepsis, COVID-19, Myelodysplastic Syndrome (MDS), and Hemolytic Disease of the Newborn.

His clinical research consists of co-authoring 42 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Thrombocytopenia.

Gender
Male

Locations

Cancercare Manitoba
Winnipeg, MB, Canada
Other Locations
Dr. Georges L-Dumont University Centre, Moncton, Canada
Ottawa, ON, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase IV Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery (TRACTION): A Pragmatic Randomized Cluster Crossover Trial
A Phase IV Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery (TRACTION): A Pragmatic Randomized Cluster Crossover Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 16, 2024
Intervention Type: Drug
Study Drug: Tranexamic Acid (TXA)
Study Phase: Phase 4

42 Total Publications

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial.
Journal: Research and practice in thrombosis and haemostasis
Published: January 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Houston's expertise for a condition
ConditionClose
        View All 16 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile